Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Treatment selection and experience in multiple sclerosis: survey of neurologists.
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Review of subcutaneous interferon β-1a, delivered via the electronic self-injection device RebiSmart™, for the treatment of multiple sclerosis.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Lodonal/LDN
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Depakote: No Prescription Cheap Low

Pages